Skip to main content
E

Epi Biotech Co., Ltd. — Investor Relations & Filings

Ticker · 446440 ISIN · KR7446440000 KO Professional, scientific and technical activities
Open in API
Filings indexed 62 across all filing types
Latest filing 2024-10-29 Report Publication Anno…
Country KR South Korea
Listing KO 446440

About Epi Biotech Co., Ltd.

https://epibiotech.com/en/

Epi Biotech Co., Ltd. is a biopharmaceutical company focused on the research and development of treatments for hair loss. The company utilizes a large genomic database and AI-driven drug discovery platforms to advance its pipeline, which includes cell and antibody therapeutics for hair restoration. In addition to its primary focus, Epi Biotech conducts R&D in skin regeneration. The company also provides specialized preclinical Contract Research Organization (CRO) services, offering expertise in hair loss research and efficacy evaluation.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최결과
Report Publication Announcement Classification · 1% confidence The document is a short, structured announcement confirming that an Investor Relations (IR) event took place on 2024-10-29. It lists the date, location, attendees, and agenda, and provides a link/reference to where the actual IR materials are posted. Since it is an announcement of an event and the availability of materials rather than the presentation deck itself, it falls under the category of a regulatory filing announcement regarding report/event publication.
2024-10-29 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회 개최). It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it is a regulatory disclosure filed with the Korea Exchange (KRX), it falls under the category of a regulatory filing or announcement of an event.
2024-10-14 Korean
합병등종료보고서(자산양수도)
M&A Activity Classification · 1% confidence The document is a 'Report on the Completion of Merger, etc.' (합병등종료보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the completion of a specific asset transfer (sale of real estate/facilities) by EpiBiotech. Since this document reports the finalization of a corporate transaction (asset disposal) rather than a merger or acquisition of another company, and it does not fit into the specific M&A category (which usually implies business combinations), it is best classified as a Regulatory Filing (RNS) as it is a formal disclosure of a completed corporate event.
2024-09-30 Korean
본점소재지변경
Regulatory Filings Classification · 1% confidence The document is a short, formal announcement regarding a change in the company's registered office address (본점소재지변경). It provides specific details such as the old address, new address, reason for change, and the date of the board resolution. Since this is a standard corporate regulatory announcement that does not fit into specific categories like financial reports, dividends, or share transactions, it falls under the general regulatory filing category.
2024-09-30 Korean
주요사항보고서(유형자산양도결정)
M&A Activity Classification · 1% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean financial authorities regarding the decision to dispose of tangible assets (유형자산 양도 결정). This is a specific regulatory disclosure required for material corporate events, such as the sale of significant assets, which does not fit into categories like M&A, share issuance, or financial reports. Therefore, it is classified as a Regulatory Filing (RNS).
2024-08-27 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 1% confidence The document is a formal notification regarding the results of an Investor Relations (IR) meeting held by EpiBiotech. It details the date, location, attendees, and agenda of the meeting. Since it reports on the occurrence and outcome of an investor event rather than being the presentation slides themselves, and it is a regulatory disclosure of an event, it fits the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2024-05-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.